Back

Receptor-guided AAV Tropism Engineering via MATCH

Graham, N.; Kumar, S.; Rainaldi, J.; Yang, S.; Portell, A.; Santoso, B.; Mali, P.

2026-04-01 synthetic biology
10.64898/2026.03.31.715691 bioRxiv
Show abstract

Precise control over viral tropism remains a major challenge in the development of gene delivery technologies. We present MATCH (Modulation of AAV Tropism through Conjugation to Homing proteins), a modular biochemical method that enables programmable, receptor-guided retargeting of adeno-associated viruses (AAVs) through site-specific covalent protein conjugation. By incorporating a SpyTag peptide motif into selected AAV capsid loops, MATCH allows one-step, stoichiometrically defined attachment of recombinant SpyCatcher-linked targeting proteins to the viral surface. Using mosaic AAV-DJ and AAV9 capsids with controlled SpyTag incorporation, we achieve efficient assembly and tunable ligand display. MATCH-AAVs conjugated to an anti-CD3 single-chain antibody efficiently activate and transduce resting human T cells within mixed PBMC populations in vitro, achieving transduction levels of up to [~]58% of total PBMCs. Conjugation to transferrin receptor (TfR1)-binding proteins yielded enhanced brain transduction in vivo, with murine TfR1-targeted MATCH-AAV9 exhibiting up to an 84-fold increase in brain expression relative to wild-type AAV9. Human TfR1-targeted vectors similarly enabled robust, receptor-dependent transduction both in vitro and in humanized mouse models. Both TfR-targeted vectors enabled widespread transduction of the parenchyma, consistent with TfR1-mediated crossing of the blood-brain barrier. Finally, we establish a streamlined one-pot "Mix-and-MATCH" production strategy in which capsid and targeting ligands are co-expressed during vector generation, yielding functional, targeted AAVs at titers comparable to conventional production. This simple and generalizable synthetic-biology approach provides a versatile toolkit for rational AAV tropism engineering, offering a scalable route to custom vector design for research and therapeutic applications. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=106 SRC="FIGDIR/small/715691v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@170a7c1org.highwire.dtl.DTLVardef@11599acorg.highwire.dtl.DTLVardef@11c0982org.highwire.dtl.DTLVardef@1b43973_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 9%
16.8%
2
Nature Biotechnology
147 papers in training set
Top 0.5%
12.0%
3
Science
429 papers in training set
Top 3%
9.7%
4
Cell
370 papers in training set
Top 2%
8.0%
5
Nature
575 papers in training set
Top 6%
4.0%
50% of probability mass above
6
Nucleic Acids Research
1128 papers in training set
Top 5%
3.8%
7
Nature Methods
336 papers in training set
Top 3%
3.8%
8
Nature Materials
21 papers in training set
Top 0.2%
3.4%
9
Nature Chemical Biology
104 papers in training set
Top 0.8%
3.4%
10
Advanced Science
249 papers in training set
Top 6%
3.1%
11
Nature Biomedical Engineering
42 papers in training set
Top 0.4%
2.6%
12
Nature Nanotechnology
30 papers in training set
Top 0.4%
2.6%
13
ACS Central Science
66 papers in training set
Top 0.9%
1.8%
14
Cell Systems
167 papers in training set
Top 8%
1.6%
15
ACS Nano
99 papers in training set
Top 2%
1.6%
16
Circulation
66 papers in training set
Top 2%
1.6%
17
Science Advances
1098 papers in training set
Top 21%
1.4%
18
Science Translational Medicine
111 papers in training set
Top 3%
1.4%
19
ACS Synthetic Biology
256 papers in training set
Top 2%
1.3%
20
Nature Neuroscience
216 papers in training set
Top 5%
1.3%
21
Cell Reports Medicine
140 papers in training set
Top 6%
1.2%
22
Nano Letters
63 papers in training set
Top 2%
0.9%
23
Angewandte Chemie International Edition
81 papers in training set
Top 3%
0.9%
24
Advanced Materials
53 papers in training set
Top 2%
0.9%
25
Molecular Therapy
71 papers in training set
Top 2%
0.9%
26
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 42%
0.9%
27
Journal of the American Chemical Society
199 papers in training set
Top 5%
0.8%
28
Cancer Cell
38 papers in training set
Top 2%
0.7%
29
Bioconjugate Chemistry
17 papers in training set
Top 0.3%
0.7%
30
Cell Reports
1338 papers in training set
Top 35%
0.7%